Rocket Pharmaceuticals Inc Announces Data Updates at the ESGCT Conference for RP-L201 for the Treatment of LAD-I

Rocket Pharmaceuticals Inc Announces Successful Results at the ESGCT
Gene therapy and gene editing plus other gene and genome-based therapeutics are the only treatments expected to lead to  miraculous cures. While genetic manipulation for the treatment of severe life-threatening diseases is still moving towards perfection, gene therapy and gene editing are accomplishing miraculous long-term effective treatments, saving thousands of lives where there are no currently approved treatments that exist to save them. 

At the 28th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT) is where we heard about successful results from . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.